Extravasation Injury Associated with Low-Dose Dopamine
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To describe the occurrence of extravasation in two patients receiving low-dose dopamine infusions. CASE SUMMARY: Intravenous dopamine was infused peripherally (in the antecubital fossa) to two patients in the cardiac intensive care unit in an attempt to enhance renal blood perfusion and urine output. Dopamine extravasation occurred in both patients while the low dose (<3 μg/kg/min) was infused. Significant local tissue injury was observed in both patients. DISCUSSION: Dopamine infusion can cause tissue ischemia or necrosis secondary to vasospasm and extravasation. Most of the case reports in the literature have occurred when relatively high doses of dopamine were infused. Only one reported extravasation-induced injury with low-dose dopamine. Although low-dose dopamine has a vasodilatory effect in selected tissues, high concentrations achieved locally as a result of extravasation can still cause severe vasoconstriction and ischemic tissue injury. CONCLUSIONS: Low-dose dopamine therapy should be administered with similar precautions as high-dose dopamine. A central intravenous access should be placed for dopamine infusion whenever possible. If this approach is not feasible, dopamine should be infused only peripherally through a long intravenous catheter into a large vein. A 5-cm angiocatheter that is 20 gauge or larger is recommended for peripheral dopamine infusion in our institution. The infusion site should be inspected frequently for early detection of extravasation, and changed to a central or a peripherally inserted central catheter as soon as possible, especially in patients at high risk for extravasation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Loubani, O. M., & Green, R. S. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.01.014 · Cited by 235
“Of the 85 included references, 80 [5–21,23–35,37–64,66,68–88] presented individual data and were made up of case studies and case series, while 5 [22,36,65,67,89] presented aggregate data and included 1 [67] randomized controlled trial and 4 [22,36,65,89] case series.”
BackgroundMethodInfluentialSafety of peripheral intravenous administration of vasoactive medication
Cardenas‐Garcia, J., Schaub, K. F., Belchikov, Y. G., Narasimhan, M., Koenig, S. J., & Mayo, P. H. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2394 · Cited by 217
“More recently, there have been anecdotal reports showing that local application of nitroglycerin paste blocks ischemic injury in the pediatric population.(5,16,17) With this information, our TABLE 3.”
Recommendations for sepsis management in resource-limited settings
Dünser, M. W., Festic, E., Dondorp, A., Kissoon, N., Ganbat, T., Kwizera, A., Haniffa, R., Baker, T., Schultz, M. J., & Global Intensive Care Working Group of the European Society of Intensive Care Medicine (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2468-5 · Cited by 176
“It is important to frequently check the site of infusion for signs of drug extravasation, since substantial skin necrosis may occur [41].”
BackgroundExtravasation injuries in adults
Al-Benna, S., O’Boyle, C., & Holley, J. (2013) · ISRN Dermatology · doi:10.1155/2013/856541 · Cited by 121
“Diabetic patients with peripheral neuropathy may not experience the pain of an infusate leaking into the subcutaneous tissues [2, 13, 19, 20], and those who suffer from superior vena cava syndrome have persistently elevated venous pressure which, again, may predispose to leakage at the intravenous site [5, 13].”
Background
Metadata
- Authors
- Chen, J. L., & O'Shea, M.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 1998-05
- Volume
- 32
- Issue
- 5
- Pages
- 545-548
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2163185693
- Cited by
- 43
- References
- 0
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.